Increasing Fluoroquinolone Resistance inCampylobacter jejuni,Pennsylvania, USA,1982–20011
Open Access
- 1 December 2002
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 8 (12) , 1501-1503
- https://doi.org/10.3201/eid0812.020115
Abstract
Fluoroquinolone-resistant Campylobacter jejuni has been observed worldwide and is now being seen in the United States. Among patients in our health-care system in Pennsylvania, fluoroquinolone-resistant C. jejuni were not observed from 1982 to 1992; however, resistance increased to 40.5% in 2001. Resistance to erythromycin remains at a low level (<5%).Keywords
This publication has 6 references indexed in Scilit:
- Quinolone and Macrolide Resistance in Campylobacter jejuni and C. coli: Resistance Mechanisms and Trends in Human IsolatesEmerging Infectious Diseases, 2001
- Empirical Antimicrobial Therapy for Traveler's DiarrheaClinical Infectious Diseases, 2000
- Genotyping of Campylobacter sppApplied and Environmental Microbiology, 2000
- Quinolone-ResistantCampylobacter jejuniInfections in Minnesota, 1992–1998New England Journal of Medicine, 1999
- Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing systemJournal of Clinical Microbiology, 1996